Loading…

Synthesis, characterization of silver nanoparticles from Punica granatum L. and its in vitro antidiabetic activity

Ecofriendly nanoparticle synthesis is an ongoing worldwide effort to treat many human diseases. In the present study, Punica granatum peel extract is a reducing agent for green synthesizing silver nanoparticles (AgNPs). Further partially characterized by preliminary phytochemical screening, UV–visib...

Full description

Saved in:
Bibliographic Details
Published in:Nanotechnology for environmental engineering 2022-12, Vol.7 (4), p.923-930
Main Authors: Saminathan, Usharani, Ramasamy, Pasiyappazham, Chinathambi, Anjalidevi, Paramasivam, Sivagurunathan, Vadamalai, Sumathi, Chinnaiyan, Uma, Singh, Rajesh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ecofriendly nanoparticle synthesis is an ongoing worldwide effort to treat many human diseases. In the present study, Punica granatum peel extract is a reducing agent for green synthesizing silver nanoparticles (AgNPs). Further partially characterized by preliminary phytochemical screening, UV–visible spectroscopy analysis, Fourier-transform infrared spectroscopy (FT-IR) and gas chromatography–mass spectroscopy analysis (GC–MS). AgNPs potential was confirmed by in vitro antidiabetic activity, and its ability to inhibit carbohydrate digesting enzymes. AgNPs showed the least inhibition of enzymes with the highest value of 84.0% at 20 mg / ml, 79.0% at 20 mg / ml concentration of α-amylase and α-glucosidase enzyme activity, respectively. The enzymatic assay results revealed the existence of AgNPs can exhibit the dose-dependent inhibition on α Amylase enzyme α-glucosidase potentials. Our results suggest that P. granatum peel extract contains (AgNPs) a good antidiabetic agent against the key enzymes involved in diabetes. Hence, moral activity can be used to make appropriate nanomedicines and pharmaceutical industries.
ISSN:2365-6379
2365-6387
DOI:10.1007/s41204-022-00278-6